With new product success rates halving in the last five years, Big Pharma’s costs are becoming “astronomical”, says Yamada. Public-private partnerships will be the key to success. An address by Tachi Yamada (This issue, RealHealthNews 5, May 2006, page 3)

Tachi Yamada to Lead Gates Foundation’s Global Health Programme

RSS,S malaria vaccine breaks 50% barrier (RealHealthNews 0, November 2004, page 8)

Tachi Yamada’s “seminal” event: story of GlaxoSmithKline’s battle with South Africa over anti-retroviral drug pricing – a compilation of reports

GlaxoSmithKline’s view of its policy towards developing countries